Multiple mechanisms of HCC suppression by BRD4 inhibition have been posited, including reduction in hyperactivity of enhancers, blockage of expression of fibrogenic proteins, and enhancement of T cell persistence and function (Yang et al., 2020). Here, BRD4 is linked to hepatocellular carcinoma.